CAS No. |
11031-11-1 |
中文名称 |
卡那霉素B氨基甲酸酯 |
英文名称 |
(2R,3S,4S,5R,6R)-2-(((2R,3S,4S,5S,6S)-2-((1R,2S)-2-(6-amino-2-((S)-3-amino-1-(((S)-2,3-diamino-3-oxopropyl)amino)-3-oxopropyl)-5-methylpyrimidine-4-carboxamido)-3-(((2R,3S,4S)-5-(((2S,3R)-1-((2-((R)-4-((4-((diaminomethylene)amino)butyl)carbamoyl)-4',5'-dihydro-[2,4'-bithiazol]-2'-yl)ethyl)amino)-3-hydroxy-1-oxobutan-2-yl)amino)-3-hydroxy-4-methyl-5-oxopentan-2-yl)amino)-1-(1H-imidazol-5-yl)-3-oxopropoxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl carbamate |
别名 |
ZEOCIN;phleomycin D1;(7R)-N1-[4-[[Amino(imino)methyl]amino]butyl]-7,8-dihydrobleomycinamide;Bleomycinamide, N1-[4-[(aminoiminomethyl)amino]butyl]-7,8-dihydro-;Zeocin (Phleomycin D1, zeomycin);ZEOCINE |
标准英文名 |
(2R,3S,4S,5R,6R)-2-(((2R,3S,4S,5S,6S)-2-((1R,2S)-2-(6-amino-2-((S)-3-amino-1-(((S)-2,3-diamino-3-oxopropyl)amino)-3-oxopropyl)-5-methylpyrimidine-4-carboxamido)-3-(((2R,3S,4S)-5-(((2S,3R)-1-((2-((R)-4-((4-((diaminomethylene)amino)butyl)carbamoyl)-4',5'-dihydro-[2,4'-bithiazol]-2'-yl)ethyl)amino)-3-hydroxy-1-oxobutan-2-yl)amino)-3-hydroxy-4-methyl-5-oxopentan-2-yl)amino)-1-(1H-imidazol-5-yl)-3-oxopropoxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl carbamate |
MDL No. |
MFCD28100499 |
分子式 |
C55H86N20O21S2 |
分子量 |
1427.55
|
精确分子量 |
1426.57
|
SMILES |
CC1=C(C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCC2=N[C@@H](C3=NC(C(=O)NCCCCN=C(N)N)=CS3)CS2)[C@@H](C)O)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]2O)C2=CN=CN2)N=C([C@H](CC(N)=O)NC[C@H](N)C(N)=O)N=C1N |
标准SMILES |
CC1C(N)=NC(=NC=1C(=O)N[C@@H]([C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)C1=CN=CN1)C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC1=N[C@H](CS1)C1=NC(=CS1)C(=O)NCCCCN=C(N)N)[C@H](CC(N)=O)NC[C@H](N)C(N)=O |
用途 |
Antitumor agent; used clinically for the treatment of squamous cell carcinoma with reduced pulmonary toxicity compared to other bleomycin variants. |
InChIKey |
CWCMIVBLVUHDHK-ZSNHEYEWSA-N |